Lucid Diagnostics Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 22 →Insiders1 insider bought $245,000 in 1 open-market buy. No sales.→HoldersAlyeska Investment 4.6%BlackRock 4.4%Vanguard 3.4%→Financing →PeersClosest companies: PAVM, VCYT, BIAF→
From the filings
Figures
- Revenue
- $5.4Mlast 12 months
- Net income
- −$52.3Mlast 12 months
- Operating cash flow
- −$46.1Mlast 12 months
- Cash and equivalents
- $47.3Mat the last balance sheet
- Shares outstanding
- 190.8M shareson issue